PeptideDB

H-Leu-Leu-Leu-OH

CAS No.: 10329-75-6

H-Leu-Leu-Leu-OH was shown to increase the endothelial release of TXB2, a stable marker of TXA2. H-Leu-Leu-Leu-OH is the
Sales Email:peptidedb@qq.com

This product is for research use only, not for human use. We do not sell to patients.

CAS 10329-75-6
Sequence H-Leu-Leu-Leu-OH
Sequence Single LLL
Molecular Formula C18H35N3O4
Molecular Weight 357.49
Technology Synthetic
Storage -20°C, avoid light, cool and dry place
Application Di- and Tripeptides
Description H-Leu-Leu-Leu-OH was shown to increase the endothelial release of TXB2, a stable marker of TXA2. H-Leu-Leu-Leu-OH is the inhibitor of human liver alanine aminopeptidase, Ki = 0.054 mM. Addition of H-Leu-Leu-Leu-OH improved aerosol performance and stability of spray-dried powders for inhalation.
References 1.  Colorimetric determination of gamma-glutamyl transpeptidase activity in human serum and tissues with synthetic substrates. M.Orlowski and A.Szewczuk, Acta Biochim. Pol., 8, 189 (1961) 2.  Higher-order complexity through R-group effects in self-assembled tripeptide monolayers. D.M.Rampulla et al., Langmuir, 26, 16287 (2010) 3.  Trileucine improves aerosol performance and stability of spray-dried powders for inhalation. D.Lechuga-Ballesteros et al., J. Pharm. Sci., 97, 287 (2008) 4.  Human liver alanine aminopeptidase. Inhibition by amino acids. C.W.Garner and F.J.Behal, Biochemistry, 14, 3208 (1975)